Brind.

MannKind Corporation Stock Declines Amid Trading Volume Drop

2 reports, 2 independent Updated Thu 00:00
No new developments lately
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

On September 22, 2026, MannKind Corporation stock traded on the Nasdaq electronic exchange. The company's stock price declined by 3.6% during mid-day trading, reaching a low of $3.28 and closing at $3.3750. Trading volume was approximately 783,383 shares, which was an 85% decline from the average session volume of 5,173,659 shares.

From tickerreport.com

Why it matters

Some supportBrind's analysis of the reports

As a small-cap healthcare company, MannKind Corporation is subject to market volatility, including a beta of 1.1 compared to the S&P 500. The company's market presence is tied to its listing on the Nasdaq stock exchange.

From themarketsdaily.com

Who's involved

  • MannKind CorporationBiopharmaceutical company whose stock is traded on the Nasdaq.
  • NasdaqElectronic stock exchange where MannKind Corporation is listed.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • MannKind CorporationSpeculative

    The company could feel the impact of the stock price decline on its market valuation.

How it developed

Newest first. Tap a step to see who reported it.
  1. MarketBeat released new analyst ratings for MannKind Corporation.1 source
  2. MannKind Corporation stock trades on the Nasdaq electronic exchange, with market data reported by MarketBeat.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped